Abstract
Despite policymakers' demand for evidence of value and sustainability for scaling and implementing interventions, few studies have assessed the cost-efficiency and financial viability of lifestyle interventions for managing gestational weight gain and reducing gestational diabetes OBJECTIVES: To describe our methodological approach for assessing the cost-effectiveness and return-on-investment (ROI) of the pragmatic (i.e., integrated into real-world prenatal care) Healthy for Two / Healthy for You (H42/H4U) lifestyle intervention versus the usual prenatal care comparison arm, using a trial-based health economic evaluation METHODS: Data from the 36-month randomized clinical trial and electronic health records will be used to estimate the intervention's effectiveness (difference in total gestational weight gain [lbs]) and its associated incremental costs. ROI and cost-effectiveness analyses will be conducted from a U.S. payer's perspective. Costs will include recruitment, intervention delivery via health coaches and an online platform, and downstream expenses. ROI and incremental cost-effectiveness ratio (ICER) will assess financial viability and cost-efficiency, respectively. Sensitivity analyses will assess the impact of variability in effectiveness and costs on the ROI and ICER DISCUSSION: Our comprehensive methodological approach for evaluating the cost-effectiveness and financial viability of the pragmatic H42/H4U lifestyle intervention integrated into prenatal care aims to address gaps in health economic evidence and support future investment decisions. Ultimately the goal is to promote the successful implementation and uptake of lifestyle interventions for improving maternal health, preventing obesity and chronic disease TRIAL REGISTRATION: The clinical trial associated with this protocol paper is registered on ClinicalTrials.gov (NCT04724330). First posted on January 26, 2021.